Prevalence, Awareness, Treatment, and Control of Hypertension in China: Results From a National Survey
BACKGROUND Hypertension is one of the major risk factor for cardiovascular disease worldwide. The objective of this study was to investigate the prevalence, awareness, treatment, and control of hypertension in China. METHODS A multistage, stratified sampling method was used to obtain a representativ...
Uložené v:
| Vydané v: | American journal of hypertension Ročník 27; číslo 11; s. 1355 - 1361 |
|---|---|
| Hlavní autori: | , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
Oxford University Press
01.11.2014
|
| Predmet: | |
| ISSN: | 0895-7061, 1941-7225, 1941-7225 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | BACKGROUND
Hypertension is one of the major risk factor for cardiovascular disease worldwide. The objective of this study was to investigate the prevalence, awareness, treatment, and control of hypertension in China.
METHODS
A multistage, stratified sampling method was used to obtain a representative sample of persons aged 18 years or older in the general population of China. Blood pressure (BP) was measured by sphygmomanometer 3 times at 5-minute intervals. Hypertension was defined as a systolic BP ≥ 140mm Hg, or diastolic BP ≥ 90mm Hg, or self-reported use of antihypertensive medications in the last 2 weeks irrespective of the BP.
RESULTS
Altogether 50,171 subjects finished the survey across the entire country. The adjusted prevalence of hypertension was 29.6% (95% confidence interval (CI) = 28.9%-30.4%) and was higher among men than among women (31.2%, 95% CI = 30.1%-32.4%; vs. 28.0%, 95% CI = 27.0%-29.0%). The awareness, treatment among all hypertensive participants, control among all hypertensive participants, and control among treated hypertensive participants were 42.6%, 34.1%, 9.3%, and 27.4%, respectively. Multiple lifestyle factors were independently associated with presence of hypertension, including physical inactivity, habitual drinking, chronic use of nonsteroidal anti-inflammatory drugs, high body mass index, and central obesity.
CONCLUSIONS
Hypertension is an important public health burden in China, and control of hypertension is still suboptimal. Several modifiable lifestyle activities were associated with hypertension and thus should be considered potential targets for intervention, with special attention to socioeconomically disadvantaged subpopulations in China. |
|---|---|
| AbstractList | BACKGROUND
Hypertension is one of the major risk factor for cardiovascular disease worldwide. The objective of this study was to investigate the prevalence, awareness, treatment, and control of hypertension in China.
METHODS
A multistage, stratified sampling method was used to obtain a representative sample of persons aged 18 years or older in the general population of China. Blood pressure (BP) was measured by sphygmomanometer 3 times at 5-minute intervals. Hypertension was defined as a systolic BP ≥ 140mm Hg, or diastolic BP ≥ 90mm Hg, or self-reported use of antihypertensive medications in the last 2 weeks irrespective of the BP.
RESULTS
Altogether 50,171 subjects finished the survey across the entire country. The adjusted prevalence of hypertension was 29.6% (95% confidence interval (CI) = 28.9%-30.4%) and was higher among men than among women (31.2%, 95% CI = 30.1%-32.4%; vs. 28.0%, 95% CI = 27.0%-29.0%). The awareness, treatment among all hypertensive participants, control among all hypertensive participants, and control among treated hypertensive participants were 42.6%, 34.1%, 9.3%, and 27.4%, respectively. Multiple lifestyle factors were independently associated with presence of hypertension, including physical inactivity, habitual drinking, chronic use of nonsteroidal anti-inflammatory drugs, high body mass index, and central obesity.
CONCLUSIONS
Hypertension is an important public health burden in China, and control of hypertension is still suboptimal. Several modifiable lifestyle activities were associated with hypertension and thus should be considered potential targets for intervention, with special attention to socioeconomically disadvantaged subpopulations in China. BACKGROUND Hypertension is one of the major risk factor for cardiovascular disease worldwide. The objective of this study was to investigate the prevalence, awareness, treatment, and control of hypertension in China. METHODS A multistage, stratified sampling method was used to obtain a representative sample of persons aged 18 years or older in the general population of China. Blood pressure (BP) was measured by sphygmomanometer 3 times at 5-minute intervals. Hypertension was defined as a systolic BP ≥ 140mm Hg, or diastolic BP ≥ 90mm Hg, or self-reported use of antihypertensive medications in the last 2 weeks irrespective of the BP. RESULTS Altogether 50,171 subjects finished the survey across the entire country. The adjusted prevalence of hypertension was 29.6% (95% confidence interval (CI) = 28.9%–30.4%) and was higher among men than among women (31.2%, 95% CI = 30.1%–32.4%; vs. 28.0%, 95% CI = 27.0%–29.0%). The awareness, treatment among all hypertensive participants, control among all hypertensive participants, and control among treated hypertensive participants were 42.6%, 34.1%, 9.3%, and 27.4%, respectively. Multiple lifestyle factors were independently associated with presence of hypertension, including physical inactivity, habitual drinking, chronic use of nonsteroidal anti-inflammatory drugs, high body mass index, and central obesity. CONCLUSIONS Hypertension is an important public health burden in China, and control of hypertension is still suboptimal. Several modifiable lifestyle activities were associated with hypertension and thus should be considered potential targets for intervention, with special attention to socioeconomically disadvantaged subpopulations in China. Hypertension is one of the major risk factor for cardiovascular disease worldwide. The objective of this study was to investigate the prevalence, awareness, treatment, and control of hypertension in China.BACKGROUNDHypertension is one of the major risk factor for cardiovascular disease worldwide. The objective of this study was to investigate the prevalence, awareness, treatment, and control of hypertension in China.A multistage, stratified sampling method was used to obtain a representative sample of persons aged 18 years or older in the general population of China. Blood pressure (BP) was measured by sphygmomanometer 3 times at 5-minute intervals. Hypertension was defined as a systolic BP ≥ 140mm Hg, or diastolic BP ≥ 90mm Hg, or self-reported use of antihypertensive medications in the last 2 weeks irrespective of the BP.METHODSA multistage, stratified sampling method was used to obtain a representative sample of persons aged 18 years or older in the general population of China. Blood pressure (BP) was measured by sphygmomanometer 3 times at 5-minute intervals. Hypertension was defined as a systolic BP ≥ 140mm Hg, or diastolic BP ≥ 90mm Hg, or self-reported use of antihypertensive medications in the last 2 weeks irrespective of the BP.Altogether 50,171 subjects finished the survey across the entire country. The adjusted prevalence of hypertension was 29.6% (95% confidence interval (CI) = 28.9%-30.4%) and was higher among men than among women (31.2%, 95% CI = 30.1%-32.4%; vs. 28.0%, 95% CI = 27.0%-29.0%). The awareness, treatment among all hypertensive participants, control among all hypertensive participants, and control among treated hypertensive participants were 42.6%, 34.1%, 9.3%, and 27.4%, respectively. Multiple lifestyle factors were independently associated with presence of hypertension, including physical inactivity, habitual drinking, chronic use of nonsteroidal anti-inflammatory drugs, high body mass index, and central obesity.RESULTSAltogether 50,171 subjects finished the survey across the entire country. The adjusted prevalence of hypertension was 29.6% (95% confidence interval (CI) = 28.9%-30.4%) and was higher among men than among women (31.2%, 95% CI = 30.1%-32.4%; vs. 28.0%, 95% CI = 27.0%-29.0%). The awareness, treatment among all hypertensive participants, control among all hypertensive participants, and control among treated hypertensive participants were 42.6%, 34.1%, 9.3%, and 27.4%, respectively. Multiple lifestyle factors were independently associated with presence of hypertension, including physical inactivity, habitual drinking, chronic use of nonsteroidal anti-inflammatory drugs, high body mass index, and central obesity.Hypertension is an important public health burden in China, and control of hypertension is still suboptimal. Several modifiable lifestyle activities were associated with hypertension and thus should be considered potential targets for intervention, with special attention to socioeconomically disadvantaged subpopulations in China.CONCLUSIONSHypertension is an important public health burden in China, and control of hypertension is still suboptimal. Several modifiable lifestyle activities were associated with hypertension and thus should be considered potential targets for intervention, with special attention to socioeconomically disadvantaged subpopulations in China. Hypertension is one of the major risk factor for cardiovascular disease worldwide. The objective of this study was to investigate the prevalence, awareness, treatment, and control of hypertension in China. A multistage, stratified sampling method was used to obtain a representative sample of persons aged 18 years or older in the general population of China. Blood pressure (BP) was measured by sphygmomanometer 3 times at 5-minute intervals. Hypertension was defined as a systolic BP ≥ 140mm Hg, or diastolic BP ≥ 90mm Hg, or self-reported use of antihypertensive medications in the last 2 weeks irrespective of the BP. Altogether 50,171 subjects finished the survey across the entire country. The adjusted prevalence of hypertension was 29.6% (95% confidence interval (CI) = 28.9%-30.4%) and was higher among men than among women (31.2%, 95% CI = 30.1%-32.4%; vs. 28.0%, 95% CI = 27.0%-29.0%). The awareness, treatment among all hypertensive participants, control among all hypertensive participants, and control among treated hypertensive participants were 42.6%, 34.1%, 9.3%, and 27.4%, respectively. Multiple lifestyle factors were independently associated with presence of hypertension, including physical inactivity, habitual drinking, chronic use of nonsteroidal anti-inflammatory drugs, high body mass index, and central obesity. Hypertension is an important public health burden in China, and control of hypertension is still suboptimal. Several modifiable lifestyle activities were associated with hypertension and thus should be considered potential targets for intervention, with special attention to socioeconomically disadvantaged subpopulations in China. |
| Author | Wang, Jinwei Zhang, Luxia Wang, Haiyan Wang, Fang Liu, Lisheng |
| Author_xml | – sequence: 1 givenname: Jinwei surname: Wang fullname: Wang, Jinwei organization: 1 Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China – sequence: 2 givenname: Luxia surname: Zhang fullname: Zhang, Luxia email: zhanglx@bjmu.edu.cn organization: 1 Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China – sequence: 3 givenname: Fang surname: Wang fullname: Wang, Fang organization: 1 Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China – sequence: 4 givenname: Lisheng surname: Liu fullname: Liu, Lisheng organization: 3 Beijing Hypertension League Institute, Beijing, China – sequence: 5 givenname: Haiyan surname: Wang fullname: Wang, Haiyan organization: 1 Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24698853$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kV9r1EAUxQep2G31xQ8gAyKIbOydf0nGB6EsrRWKitbnYTq5cbMkM3EmWdlv39GtRYv4dB_O7x7uueeIHPjgkZCnDF4z0OLEbtYn63EGJR6QBdOSFRXn6oAsoNaqqKBkh-QopQ0AyLJkj8ghl6WuayUWpP0UcWt79A6X9PSHjegxpSW9iminAf20pNY3dBX8FENPQ0svdiPGCX3qgqedp6t15-0b-hnT3E-JnscwUEs_2Cnrtqdf5rjF3WPysLV9wie385h8PT-7Wl0Ulx_fvV-dXhZOAZ8K10ghFLNSaWtdybBuG8YbzpyqFEomrmsNpVQVciecBuCq0S1UTlZOiawfk7d733G-HrBxOUC0vRljN9i4M8F25m_Fd2vzLWyN5KXQQmaDl7cGMXyfMU1m6JLDvrcew5wMK0ErkBpERp_fQzdhjjlzMlxAKTjUSmfq2Z8X3Z3yu4IMvNoDLoaUIrZ3CAPzs1-T-zX7fjMM92DXTb9endN0_b9XXuxXwjz-z_oGpqa10A |
| CitedBy_id | crossref_primary_10_1097_HJH_0000000000002793 crossref_primary_10_1186_s41256_016_0013_8 crossref_primary_10_1038_s41371_018_0082_x crossref_primary_10_1186_s12872_021_02427_2 crossref_primary_10_1111_1753_0407_12333 crossref_primary_10_3892_etm_2018_7107 crossref_primary_10_1371_journal_pone_0152182 crossref_primary_10_1038_jhh_2016_23 crossref_primary_10_1186_s12889_018_5276_1 crossref_primary_10_1097_HJH_0000000000000818 crossref_primary_10_2188_jea_JE20200497 crossref_primary_10_1038_s41371_021_00570_z crossref_primary_10_1080_10641963_2019_1619753 crossref_primary_10_1016_j_jalz_2015_02_011 crossref_primary_10_1080_16549716_2022_2129131 crossref_primary_10_1159_000481280 crossref_primary_10_1186_s12872_021_02333_7 crossref_primary_10_1136_bmjopen_2018_025915 crossref_primary_10_1371_journal_pmed_1001860 crossref_primary_10_1038_s41598_021_04735_1 crossref_primary_10_1080_00207233_2025_2464470 crossref_primary_10_1093_ageing_afaa048 crossref_primary_10_1186_s12889_021_10417_4 crossref_primary_10_1155_2018_5231048 crossref_primary_10_1097_CM9_0000000000001949 crossref_primary_10_3389_fpubh_2022_768471 crossref_primary_10_1111_nep_12449 crossref_primary_10_1038_510S4a crossref_primary_10_1016_j_ijcard_2017_05_003 crossref_primary_10_1038_jhh_2016_1 crossref_primary_10_1186_s12872_020_01773_x crossref_primary_10_1097_MD_0000000000021465 crossref_primary_10_1038_s41371_018_0029_2 crossref_primary_10_1111_ijcp_13426 crossref_primary_10_1038_s41598_019_46857_7 crossref_primary_10_1038_s41598_023_28407_4 crossref_primary_10_1007_s11655_019_2705_7 crossref_primary_10_1080_10641963_2018_1489544 crossref_primary_10_3109_10641963_2014_960973 crossref_primary_10_1016_j_eujim_2018_04_004 crossref_primary_10_1136_jech_2015_206492 crossref_primary_10_1186_s12889_020_09858_0 crossref_primary_10_1038_s41371_018_0088_4 crossref_primary_10_1097_MD_0000000000006423 crossref_primary_10_1016_j_jstrokecerebrovasdis_2018_03_009 crossref_primary_10_1111_jch_12658 crossref_primary_10_1097_HJH_0000000000001122 crossref_primary_10_3390_ijerph182312378 crossref_primary_10_24171_j_phrp_2017_8_3_05 crossref_primary_10_1002_ajpa_24032 crossref_primary_10_1186_s12877_024_04656_4 crossref_primary_10_1001_jamainternmed_2022_6817 crossref_primary_10_1097_MD_0000000000016116 crossref_primary_10_1210_jc_2017_01530 crossref_primary_10_1155_2015_897070 crossref_primary_10_1097_MD_0000000000014292 crossref_primary_10_1097_MD_0000000000020967 crossref_primary_10_1177_1474515115603902 crossref_primary_10_1186_s12872_021_01885_y crossref_primary_10_3389_fpsyt_2020_00591 crossref_primary_10_4103_0366_6999_222332 crossref_primary_10_1038_s41371_018_0039_0 crossref_primary_10_1186_s12902_019_0390_3 crossref_primary_10_1016_j_jtrangeo_2017_07_004 crossref_primary_10_1007_s12012_021_09671_0 crossref_primary_10_1016_j_schres_2016_09_001 crossref_primary_10_1186_s12889_016_3008_y crossref_primary_10_1155_2018_5610725 crossref_primary_10_1186_s12939_017_0545_7 crossref_primary_10_1007_s11684_021_0871_4 crossref_primary_10_1007_s11783_018_1053_8 crossref_primary_10_1186_s12872_022_02769_5 crossref_primary_10_1111_ggi_13317 crossref_primary_10_1177_0300060520903645 crossref_primary_10_1016_j_numecd_2020_11_022 crossref_primary_10_1007_s10653_022_01317_6 crossref_primary_10_1111_jch_13848 crossref_primary_10_7189_jogh_11_08005 crossref_primary_10_1038_s41371_019_0276_x crossref_primary_10_1136_bmjopen_2019_029249 crossref_primary_10_1016_j_jacc_2019_04_036 crossref_primary_10_1136_bmjopen_2016_012404 crossref_primary_10_1016_j_envint_2024_108858 crossref_primary_10_1038_jhh_2016_73 crossref_primary_10_3233_JAD_190944 crossref_primary_10_1111_cns_12543 crossref_primary_10_1016_j_jtcvs_2015_11_056 crossref_primary_10_1016_j_ijcard_2015_03_045 crossref_primary_10_1136_bmjopen_2018_027215 crossref_primary_10_1002_ejhf_1630 crossref_primary_10_1080_10641963_2017_1281948 crossref_primary_10_3389_fcvm_2022_912197 crossref_primary_10_1007_s11239_020_02256_8 crossref_primary_10_1038_s41371_018_0158_7 crossref_primary_10_1080_10641963_2018_1445751 crossref_primary_10_1136_bmjopen_2023_072854 crossref_primary_10_1038_jhh_2016_81 crossref_primary_10_1093_ajh_hpz003 crossref_primary_10_2147_RMHP_S341148 crossref_primary_10_1136_bmjnph_2020_000165 crossref_primary_10_1016_j_ijnurstu_2017_10_006 crossref_primary_10_1038_s41598_018_19740_0 crossref_primary_10_1186_s12889_019_6753_x crossref_primary_10_1001_jamanetworkopen_2024_49561 crossref_primary_10_1007_s00059_016_4489_2 crossref_primary_10_1007_s40261_018_0700_y crossref_primary_10_1038_s41598_021_92319_4 crossref_primary_10_1177_03000605211010051 crossref_primary_10_1002_hsr2_120 crossref_primary_10_1097_HJH_0000000000000478 crossref_primary_10_1097_HJH_0000000000001203 crossref_primary_10_1186_s13104_019_4417_7 crossref_primary_10_1186_s12889_020_8377_6 crossref_primary_10_1155_2019_8268573 crossref_primary_10_1161_HYPERTENSIONAHA_117_09404 crossref_primary_10_1088_1742_6596_1496_1_012014 crossref_primary_10_1111_phn_13470 crossref_primary_10_2196_65783 crossref_primary_10_2147_TCRM_S321799 crossref_primary_10_3390_ijerph14010001 crossref_primary_10_1186_s12913_020_05194_6 crossref_primary_10_1212_WNL_0000000000209982 crossref_primary_10_1186_s12872_019_1115_2 crossref_primary_10_1038_s41371_019_0263_2 crossref_primary_10_1080_10641963_2021_2022688 crossref_primary_10_1161_ATVBAHA_116_308515 crossref_primary_10_1186_s12889_020_09862_4 crossref_primary_10_1097_jnr_0000000000000325 crossref_primary_10_1177_2040622320922020 crossref_primary_10_3389_fnins_2021_749949 crossref_primary_10_1136_bmjopen_2016_015206 crossref_primary_10_1016_j_jstrokecerebrovasdis_2020_105087 crossref_primary_10_1186_s12967_022_03309_7 crossref_primary_10_1016_S0140_6736_17_32478_9 crossref_primary_10_1186_s12889_024_18113_9 crossref_primary_10_4103_0366_6999_206343 crossref_primary_10_1038_s41598_023_42247_2 crossref_primary_10_1038_s41440_018_0118_1 crossref_primary_10_1186_s12944_022_01647_5 crossref_primary_10_2196_11280 crossref_primary_10_1038_s41371_023_00861_7 crossref_primary_10_2196_38782 crossref_primary_10_1007_s10067_017_3548_2 crossref_primary_10_1093_ajh_hpu166 crossref_primary_10_1016_j_aogh_2016_02_002 crossref_primary_10_1089_met_2019_0009 crossref_primary_10_1186_s13293_020_00317_4 crossref_primary_10_1007_s40520_019_01356_7 crossref_primary_10_1097_MD_0000000000016058 crossref_primary_10_1177_1747493017694391 crossref_primary_10_3389_fpubh_2022_865870 crossref_primary_10_1038_s41371_020_0367_8 crossref_primary_10_1080_03007995_2019_1596630 crossref_primary_10_1186_s12877_023_03836_y crossref_primary_10_1038_s41598_019_52132_6 crossref_primary_10_1186_s12199_017_0634_7 crossref_primary_10_3390_ijerph16101721 crossref_primary_10_1016_j_hlc_2015_12_093 crossref_primary_10_1038_s41371_018_0059_9 crossref_primary_10_1089_met_2020_0003 crossref_primary_10_3389_fpubh_2022_802195 crossref_primary_10_1080_10641963_2018_1545845 crossref_primary_10_1136_bmjopen_2021_056395 crossref_primary_10_3390_nu10081091 crossref_primary_10_1038_s41598_024_62588_w crossref_primary_10_1161_STROKEAHA_116_014578 crossref_primary_10_3390_ijerph13121199 crossref_primary_10_1038_s41371_019_0247_2 crossref_primary_10_1017_thg_2016_95 crossref_primary_10_3389_fpubh_2020_00070 crossref_primary_10_1080_03007995_2025_2502674 crossref_primary_10_1177_1747493019851280 crossref_primary_10_1155_2021_8976625 crossref_primary_10_4240_wjgs_v14_i8_743 crossref_primary_10_1161_JAHA_117_005561 crossref_primary_10_3390_antiox12010165 crossref_primary_10_3390_nu14091832 crossref_primary_10_1038_s41598_017_17068_9 crossref_primary_10_1177_1747493018816515 crossref_primary_10_1038_srep38768 crossref_primary_10_1016_j_scitotenv_2017_11_343 crossref_primary_10_1038_s41440_023_01183_4 crossref_primary_10_1016_j_semnephrol_2017_02_006 crossref_primary_10_1089_jwh_2021_0430 crossref_primary_10_1016_j_gheart_2015_12_008 crossref_primary_10_1186_s12875_023_02139_w crossref_primary_10_1371_journal_pone_0225906 crossref_primary_10_1111_nep_13489 crossref_primary_10_3389_fphys_2019_00440 crossref_primary_10_1093_ajh_hpab040 crossref_primary_10_1007_s11684_017_0578_8 crossref_primary_10_1186_s12889_015_1687_4 crossref_primary_10_3389_fcvm_2019_00119 crossref_primary_10_1136_bmjopen_2020_048396 crossref_primary_10_1016_j_jash_2018_03_013 crossref_primary_10_1161_HYPERTENSIONAHA_116_08499 crossref_primary_10_1080_10641963_2018_1431252 crossref_primary_10_1016_j_puhip_2021_100119 crossref_primary_10_1080_10641963_2018_1523914 crossref_primary_10_1038_s41598_019_54827_2 crossref_primary_10_1186_s41043_021_00237_y crossref_primary_10_1007_s10072_020_04919_z crossref_primary_10_1371_journal_pone_0269777 crossref_primary_10_1093_ajh_hpab038 crossref_primary_10_1111_1753_0407_12863 crossref_primary_10_1371_journal_pone_0133828 crossref_primary_10_1007_s00394_018_1687_0 crossref_primary_10_1186_s12877_019_1262_4 crossref_primary_10_1186_s12913_022_08232_7 crossref_primary_10_1016_j_jash_2018_03_009 crossref_primary_10_1097_01_EPX_0000470547_32952_cf crossref_primary_10_1002_jat_3968 crossref_primary_10_1161_CIRCULATIONAHA_117_032380 crossref_primary_10_1177_2047487315617105 crossref_primary_10_1007_s11906_018_0839_1 crossref_primary_10_1186_s12877_023_03879_1 crossref_primary_10_1186_s41256_018_0076_9 crossref_primary_10_1002_VIW_20240059 crossref_primary_10_3389_fcvm_2024_1335823 crossref_primary_10_1038_s41371_017_0003_4 crossref_primary_10_1371_journal_pone_0139442 crossref_primary_10_1155_2019_9602783 crossref_primary_10_1038_jhh_2015_13 crossref_primary_10_1136_bmj_2022_071952 crossref_primary_10_1371_journal_pone_0155801 crossref_primary_10_1089_bfm_2017_0180 crossref_primary_10_1016_j_cjca_2015_07_734 crossref_primary_10_1093_eurheartj_suw030 crossref_primary_10_1093_ajh_hpab019 crossref_primary_10_2147_CLEP_S322791 crossref_primary_10_1016_j_biosystems_2018_08_002 crossref_primary_10_1093_ajh_hpx222 crossref_primary_10_1186_s12913_019_4289_5 crossref_primary_10_3390_ijerph14040376 crossref_primary_10_1097_MD_0000000000025192 crossref_primary_10_1007_s00038_019_01276_3 crossref_primary_10_1139_apnm_2016_0660 crossref_primary_10_1007_s42399_024_01660_y crossref_primary_10_1097_HJH_0000000000002905 crossref_primary_10_1111_jcpt_12549 crossref_primary_10_1016_j_scib_2018_03_006 crossref_primary_10_7189_jogh_10_010805 crossref_primary_10_1097_MBP_0000000000000276 crossref_primary_10_1186_s12913_016_1673_2 crossref_primary_10_1016_j_nut_2018_02_020 crossref_primary_10_1371_journal_pone_0141749 crossref_primary_10_1016_j_ijcard_2016_06_032 crossref_primary_10_1016_j_maturitas_2023_04_009 crossref_primary_10_1111_cns_12846 crossref_primary_10_1186_s12872_018_0761_0 crossref_primary_10_1016_j_jstrokecerebrovasdis_2016_12_002 crossref_primary_10_1080_10641963_2019_1590383 crossref_primary_10_1136_bmjopen_2017_020126 crossref_primary_10_1093_ajh_hpx139 crossref_primary_10_1053_j_ajkd_2019_05_032 crossref_primary_10_1371_journal_pone_0143924 crossref_primary_10_1161_HYPERTENSIONAHA_117_09801 crossref_primary_10_1080_10641963_2020_1790584 crossref_primary_10_1016_j_sjbs_2021_06_014 crossref_primary_10_3390_ijerph14101256 crossref_primary_10_1017_S136898001900301X crossref_primary_10_3390_ijerph13020233 crossref_primary_10_1186_s12939_016_0441_6 crossref_primary_10_1038_s41598_018_23356_9 crossref_primary_10_1007_s12325_024_02997_5 crossref_primary_10_1371_journal_pone_0206635 crossref_primary_10_3389_fnut_2021_728774 crossref_primary_10_5334_aogh_2398 crossref_primary_10_1177_2150131915614069 crossref_primary_10_1186_s12882_020_01761_5 crossref_primary_10_1371_journal_pone_0195340 crossref_primary_10_1038_hr_2014_172 crossref_primary_10_1097_HJH_0000000000000745 crossref_primary_10_1016_j_jash_2014_09_018 crossref_primary_10_1155_2022_2054876 crossref_primary_10_1186_s13063_015_1131_1 crossref_primary_10_1111_jch_12575 crossref_primary_10_1155_2019_4634823 |
| Cites_doi | 10.1161/CIRCULATIONAHA.108.788166 10.1161/01.HYP.0000040263.94619.D5 10.1001/jama.2009.726 10.1016/S0140-6736(12)60278-5 10.1097/HJH.0b013e328334b39e 10.1038/ajh.2012.11 10.1001/archinte.168.7.713 10.1093/ajh/hpt111 10.1093/alcalc/agh018 10.1161/01.HYP.0000252676.46043.18 10.1016/S0140-6736(08)61366-5 10.1097/HJH.0b013e32833a38f2 10.1097/HCO.0b013e3283021c70 10.1097/HJH.0b013e328347f79e 10.1016/j.ijcard.2012.04.140 10.1097/00004872-200311000-00002 10.1093/alcalc/ags037 10.1016/S0140-6736(05)17741-1 10.1016/S0140-6736(09)61199-5 10.1016/S0140-6736(12)60033-6 10.1038/jhh.2012.56 10.1097/HJH.0b013e3283568158 |
| ContentType | Journal Article |
| Contributor | Zhang, Jian E Liu, Fu You Wang, Wen ke Liu, Bi Cheng Yu, Xue Qing Wang, Li Zhou, Xiao Ling Chen, Meng Hua Wang, Wei Ming Ma, Li Jie Liu, Hong Hu, Zhao Chen, Nan Chen, Wei Hong, Da Qing Chen, Jiang Hua Liu, Jian He, Qiang Pan, Ling Liao, Yun Hua |
| Contributor_xml | – sequence: 1 givenname: Li surname: Wang fullname: Wang, Li – sequence: 2 givenname: Wen ke surname: Wang fullname: Wang, Wen ke – sequence: 3 givenname: Bi Cheng surname: Liu fullname: Liu, Bi Cheng – sequence: 4 givenname: Jian surname: Liu fullname: Liu, Jian – sequence: 5 givenname: Meng Hua surname: Chen fullname: Chen, Meng Hua – sequence: 6 givenname: Qiang surname: He fullname: He, Qiang – sequence: 7 givenname: Yun Hua surname: Liao fullname: Liao, Yun Hua – sequence: 8 givenname: Xue Qing surname: Yu fullname: Yu, Xue Qing – sequence: 9 givenname: Nan surname: Chen fullname: Chen, Nan – sequence: 10 givenname: Jian E surname: Zhang fullname: Zhang, Jian E – sequence: 11 givenname: Zhao surname: Hu fullname: Hu, Zhao – sequence: 12 givenname: Fu You surname: Liu fullname: Liu, Fu You – sequence: 13 givenname: Da Qing surname: Hong fullname: Hong, Da Qing – sequence: 14 givenname: Li Jie surname: Ma fullname: Ma, Li Jie – sequence: 15 givenname: Hong surname: Liu fullname: Liu, Hong – sequence: 16 givenname: Xiao Ling surname: Zhou fullname: Zhou, Xiao Ling – sequence: 17 givenname: Jiang Hua surname: Chen fullname: Chen, Jiang Hua – sequence: 18 givenname: Ling surname: Pan fullname: Pan, Ling – sequence: 19 givenname: Wei surname: Chen fullname: Chen, Wei – sequence: 20 givenname: Wei Ming surname: Wang fullname: Wang, Wei Ming |
| Copyright | American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2014 American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com. American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com |
| Copyright_xml | – notice: American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2014 – notice: American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com. – notice: American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com |
| CorporateAuthor | the China National Survey of Chronic Kidney Disease Working Group China National Survey of Chronic Kidney Disease Working Group |
| CorporateAuthor_xml | – name: the China National Survey of Chronic Kidney Disease Working Group – name: China National Survey of Chronic Kidney Disease Working Group |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1093/ajh/hpu053 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest One Academic Middle East (New) MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1941-7225 |
| EndPage | 1361 |
| ExternalDocumentID | PMC4263934 24698853 10_1093_ajh_hpu053 10.1093/ajh/hpu053 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GroupedDBID | --- .2P .I3 .ZR 0R~ 1TH 23M 39C 4.4 48X 53G 5GY 5RE 5WD 70F 7X7 88E 8FI 8FJ AABZA AACZT AAJKP AAJQQ AAMVS AAOGV AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABNHQ ABNKS ABOCM ABPQP ABPTD ABQLI ABQNK ABUWG ABVGC ABWST ABXVV ABZBJ ACGFS ACUFI ACUTJ ACUTO ACYHN ADBBV ADEYI ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZXQ AEGPL AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFKRA AFOFC AFXAL AGINJ AGQXC AGSYK AGUTN AHMBA AHMMS AHXPO AJEEA AJNCP AKRWK ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT ATGXG AVWKF AXUDD BAYMD BCRHZ BENPR BEYMZ BHONS BPHCQ BTRTY BVRKM BVXVI C45 CCPQU CDBKE CS3 DAKXR DILTD D~K EBS EE~ EJD EMOBN ENERS F5P F9B FDB FECEO FLUFQ FOEOM FOTVD FQBLK FYUFA G-Q GAUVT GJXCC H13 H5~ HAR HMCUK HW0 HZ~ J21 JXSIZ KBUDW KOP KSI KSN M1P MHKGH ML0 NGC NOMLY NOYVH NVLIB O9- OAUYM OAWHX OCZFY ODMLO OJQWA OJZSN OPAEJ OVD OWPYF O~Y P2P PAFKI PEELM PHGZT PQQKQ PROAC PSQYO Q1. Q5Y ROX ROZ RPZ RUSNO RW1 RXO TEORI TJX UKHRP WH7 YAYTL YKOAZ YXANX AAFWJ AAYXX AFFHD AJBYB CITATION PHGZM PJZUB PPXIY --K .55 .GJ 1B1 1~5 4G. 5VS 7-5 AAEDT AALRI AAPGJ AAQXK AAWDT AAXUO ABMAC ABNGD ABSMQ ABWVN ACFRR ACIUM ACRPL ACUKT ACVCV ACVFH ACZBC ADCNI ADMTO ADMUD ADNMO AEUPX AFFNX AFFQV AFPUW AFYAG AGKRT AGMDO AGORE AGQPQ AHGBF AIGII AITUG AJDVS APJGH AQDSO AQKUS ASPBG AVNTJ AZFZN BZKNY CAG CGR COF CUY CVF ECM EIF EIHJH EO8 FEDTE FGOYB HVGLF IHE JSO M41 MBLQV NPM NQ- NU- O0~ OBFPC PB- R2- RIG ROL SDP SSZ TMA X7M XPP YYP ZGI ZXP 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c502t-cd43351a459aac61e8fd12d21c575e413b8906457e2c3c90025d9f07c47c53413 |
| IEDL.DBID | 7X7 |
| ISICitedReferencesCount | 322 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000344601100005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0895-7061 1941-7225 |
| IngestDate | Tue Nov 04 01:45:49 EST 2025 Sun Nov 09 10:10:59 EST 2025 Sat Nov 29 14:58:44 EST 2025 Mon Jul 21 06:01:29 EDT 2025 Sat Nov 29 02:35:39 EST 2025 Tue Nov 18 22:08:04 EST 2025 Wed Apr 02 07:03:29 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | blood pressure epidemiology prevalence hypertension China |
| Language | English |
| License | American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c502t-cd43351a459aac61e8fd12d21c575e413b8906457e2c3c90025d9f07c47c53413 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://academic.oup.com/ajh/article-pdf/27/11/1355/8663566/hpu053.pdf |
| PMID | 24698853 |
| PQID | 2306320859 |
| PQPubID | 536305 |
| PageCount | 7 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4263934 proquest_miscellaneous_1609504903 proquest_journals_2306320859 pubmed_primary_24698853 crossref_primary_10_1093_ajh_hpu053 crossref_citationtrail_10_1093_ajh_hpu053 oup_primary_10_1093_ajh_hpu053 |
| PublicationCentury | 2000 |
| PublicationDate | 2014-11-01 |
| PublicationDateYYYYMMDD | 2014-11-01 |
| PublicationDate_xml | – month: 11 year: 2014 text: 2014-11-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Oxford – name: US |
| PublicationTitle | American journal of hypertension |
| PublicationTitleAlternate | Am J Hypertens |
| PublicationYear | 2014 |
| Publisher | Oxford University Press |
| Publisher_xml | – name: Oxford University Press |
| References | (4_44855653) 2012; 25 Fung (9_30762463) 2008; 168 Meng (7_42051353) 2012; 379 (11_45407651) 2002; 40 Ebrahimi (18_37680650) 2010; 28 Aekplakorn (17_43294394) 2012; 30 Xie (23_30939381) 2008; 37 Meng (14_39902833) 2011; 29 (22_42336797) 2012; 47 (16_45369119) 2007; 49 He (5_35730846) 2009; 374 Xi (12_42713808) 2012; 158 (19_47680972) 2013; 27 Wu (3_32964225) 2008; 118 Kearney (1_18620387) 2005; 365 Whitworth (2_17888702) 2003; 21 Li (13_36501912) 2010; 28 Yang (6_32312984) 2008; 372 (15_46122360) 2013; 26 Chan (24_34889652) 2009; 301 Tao (10_16031138) 1995; 108 Grotto (20_31246488) 2008; 23 Hao (21_17968609) 2004; 39 Zhang (8_42051354) 2012; 379 25293937 - Am J Hypertens. 2014 Nov;27(11):1426 25293938 - Am J Hypertens. 2014 Nov;27(11):1427 22828082 - J Hypertens. 2012 Sep;30(9):1734-42 19106390 - Circulation. 2008 Dec 16;118(25):2679-86 22493047 - Alcohol Alcohol. 2012 Jul-Aug;47(4):464-72 22626836 - Int J Cardiol. 2012 Jul 12;158(2):326-9 23223084 - J Hum Hypertens. 2013 Jun;27(6):381-7 21558952 - J Hypertens. 2011 Jul;29(7):1303-10 18413553 - Arch Intern Med. 2008 Apr 14;168(7):713-20 20087215 - J Hypertens. 2010 Mar;28(3):432-8 22386035 - Lancet. 2012 Mar 3;379(9818):815-22 14691074 - Alcohol Alcohol. 2004 Jan-Feb;39(1):43-52 18520717 - Curr Opin Cardiol. 2008 Jul;23(4):335-9 14597836 - J Hypertens. 2003 Nov;21(11):1983-92 18421859 - Wei Sheng Yan Jiu. 2008 Jan;37(1):33-6 20647858 - J Hypertens. 2010 Aug;28(8):1620-9 22386034 - Lancet. 2012 Mar 3;379(9818):805-14 23846723 - Am J Hypertens. 2013 Nov;26(11):1335-45 17159087 - Hypertension. 2007 Jan;49(1):69-75 22337206 - Am J Hypertens. 2012 May;25(5):590-6 7555263 - Chin Med J (Engl). 1995 Jul;108(7):483-9 12468580 - Hypertension. 2002 Dec;40(6):920-7 15652604 - Lancet. 2005 Jan 15-21;365(9455):217-23 18930526 - Lancet. 2008 Nov 8;372(9650):1697-705 19811816 - Lancet. 2009 Nov 21;374(9703):1765-72 19470990 - JAMA. 2009 May 27;301(20):2129-40 |
| References_xml | – volume: 118 start-page: 2679 issn: 0009-7322 issue: 25 year: 2008 ident: 3_32964225 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.788166 – volume: 40 start-page: 920 year: 2002 ident: 11_45407651 publication-title: OCL Hypertension doi: 10.1161/01.HYP.0000040263.94619.D5 – volume: 301 start-page: 2129 issn: 0098-7484 issue: 20 year: 2009 ident: 24_34889652 publication-title: JAMA doi: 10.1001/jama.2009.726 – volume: 379 start-page: 805 issn: 0140-6736 issue: 9818 year: 2012 ident: 7_42051353 publication-title: Lancet doi: 10.1016/S0140-6736(12)60278-5 – volume: 28 start-page: 432 issn: 0263-6352 issue: 3 year: 2010 ident: 13_36501912 publication-title: Journal of hypertension doi: 10.1097/HJH.0b013e328334b39e – volume: 25 start-page: 590 issn: 0895-7061 issue: 5 year: 2012 ident: 4_44855653 publication-title: American Journal of Hypertension doi: 10.1038/ajh.2012.11 – volume: 168 start-page: 713 issn: 0003-9926 issue: 7 year: 2008 ident: 9_30762463 publication-title: Archives of Internal Medicine doi: 10.1001/archinte.168.7.713 – volume: 26 start-page: 1335 issn: 0895-7061 issue: 11 year: 2013 ident: 15_46122360 publication-title: American Journal of Hypertension doi: 10.1093/ajh/hpt111 – volume: 39 start-page: 43 issn: 0735-0414 issue: 1 year: 2004 ident: 21_17968609 publication-title: Alcohol and Alcoholism doi: 10.1093/alcalc/agh018 – volume: 49 start-page: 69 year: 2007 ident: 16_45369119 publication-title: OCL Hypertension doi: 10.1161/01.HYP.0000252676.46043.18 – volume: 372 start-page: 1697 issn: 0140-6736 issue: 9650 year: 2008 ident: 6_32312984 publication-title: Lancet doi: 10.1016/S0140-6736(08)61366-5 – volume: 28 start-page: 1620 issn: 0263-6352 issue: 8 year: 2010 ident: 18_37680650 publication-title: Journal of hypertension doi: 10.1097/HJH.0b013e32833a38f2 – volume: 23 start-page: 335 issn: 0268-4705 issue: 4 year: 2008 ident: 20_31246488 publication-title: Current opinion in cardiology doi: 10.1097/HCO.0b013e3283021c70 – volume: 29 start-page: 1303 issn: 0263-6352 issue: 7 year: 2011 ident: 14_39902833 publication-title: Journal of hypertension doi: 10.1097/HJH.0b013e328347f79e – volume: 158 start-page: 326 issn: 0167-5273 issue: 2 year: 2012 ident: 12_42713808 publication-title: International journal of cardiology doi: 10.1016/j.ijcard.2012.04.140 – volume: 21 start-page: 1983 issn: 0263-6352 issue: 11 year: 2003 ident: 2_17888702 publication-title: Journal of hypertension doi: 10.1097/00004872-200311000-00002 – volume: 108 start-page: 483 issn: 0366-6999 issue: 7 year: 1995 ident: 10_16031138 publication-title: Chinese medical journal – volume: 47 start-page: 464 issn: 0735-0414 issue: 4 year: 2012 ident: 22_42336797 publication-title: Alcohol and Alcoholism doi: 10.1093/alcalc/ags037 – volume: 37 start-page: 33 issn: 1000-8020 issue: 1 year: 2008 ident: 23_30939381 publication-title: Wei sheng yan jiu = Journal of hygiene research – volume: 365 start-page: 217 issn: 0140-6736 issue: 9455 year: 2005 ident: 1_18620387 publication-title: Lancet doi: 10.1016/S0140-6736(05)17741-1 – volume: 374 start-page: 1765 issn: 0140-6736 issue: 9703 year: 2009 ident: 5_35730846 publication-title: Lancet doi: 10.1016/S0140-6736(09)61199-5 – volume: 379 start-page: 815 issn: 0140-6736 issue: 9818 year: 2012 ident: 8_42051354 publication-title: Lancet doi: 10.1016/S0140-6736(12)60033-6 – volume: 27 start-page: 381 issn: 0950-9240 year: 2013 ident: 19_47680972 publication-title: Journal of human hypertension doi: 10.1038/jhh.2012.56 – volume: 30 start-page: 1734 issn: 0263-6352 issue: 9 year: 2012 ident: 17_43294394 publication-title: Journal of hypertension doi: 10.1097/HJH.0b013e3283568158 – reference: 12468580 - Hypertension. 2002 Dec;40(6):920-7 – reference: 25293937 - Am J Hypertens. 2014 Nov;27(11):1426 – reference: 18421859 - Wei Sheng Yan Jiu. 2008 Jan;37(1):33-6 – reference: 22493047 - Alcohol Alcohol. 2012 Jul-Aug;47(4):464-72 – reference: 23846723 - Am J Hypertens. 2013 Nov;26(11):1335-45 – reference: 19106390 - Circulation. 2008 Dec 16;118(25):2679-86 – reference: 18930526 - Lancet. 2008 Nov 8;372(9650):1697-705 – reference: 22386034 - Lancet. 2012 Mar 3;379(9818):805-14 – reference: 17159087 - Hypertension. 2007 Jan;49(1):69-75 – reference: 23223084 - J Hum Hypertens. 2013 Jun;27(6):381-7 – reference: 22828082 - J Hypertens. 2012 Sep;30(9):1734-42 – reference: 22337206 - Am J Hypertens. 2012 May;25(5):590-6 – reference: 7555263 - Chin Med J (Engl). 1995 Jul;108(7):483-9 – reference: 25293938 - Am J Hypertens. 2014 Nov;27(11):1427 – reference: 14597836 - J Hypertens. 2003 Nov;21(11):1983-92 – reference: 19811816 - Lancet. 2009 Nov 21;374(9703):1765-72 – reference: 20647858 - J Hypertens. 2010 Aug;28(8):1620-9 – reference: 21558952 - J Hypertens. 2011 Jul;29(7):1303-10 – reference: 19470990 - JAMA. 2009 May 27;301(20):2129-40 – reference: 18520717 - Curr Opin Cardiol. 2008 Jul;23(4):335-9 – reference: 20087215 - J Hypertens. 2010 Mar;28(3):432-8 – reference: 22386035 - Lancet. 2012 Mar 3;379(9818):815-22 – reference: 14691074 - Alcohol Alcohol. 2004 Jan-Feb;39(1):43-52 – reference: 22626836 - Int J Cardiol. 2012 Jul 12;158(2):326-9 – reference: 18413553 - Arch Intern Med. 2008 Apr 14;168(7):713-20 – reference: 15652604 - Lancet. 2005 Jan 15-21;365(9455):217-23 |
| SSID | ssj0004661 |
| Score | 2.5915318 |
| SecondaryResourceType | review_article |
| Snippet | BACKGROUND
Hypertension is one of the major risk factor for cardiovascular disease worldwide. The objective of this study was to investigate the prevalence,... Hypertension is one of the major risk factor for cardiovascular disease worldwide. The objective of this study was to investigate the prevalence, awareness,... BACKGROUND Hypertension is one of the major risk factor for cardiovascular disease worldwide. The objective of this study was to investigate the prevalence,... |
| SourceID | pubmedcentral proquest pubmed crossref oup |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1355 |
| SubjectTerms | Adolescent Adult Alcohol Antihypertensive Agents - therapeutic use Antihypertensives Asian Continental Ancestry Group - psychology Awareness Blood pressure Blood Pressure - drug effects Cardiovascular disease China - epidemiology Diabetes Epidemiology Family medical history Female Health Behavior - ethnology Health Care Surveys Health Knowledge, Attitudes, Practice - ethnology Health surveys Humans Hypertension Hypertension - diagnosis Hypertension - drug therapy Hypertension - ethnology Hypertension - physiopathology Hypertension - psychology Kidney diseases Life Style - ethnology Lifestyles Male Middle Aged Original Prevalence Public health Risk Factors Risk Reduction Behavior Rural areas Sex Distribution Sex Factors Treatment Outcome Young Adult |
| Title | Prevalence, Awareness, Treatment, and Control of Hypertension in China: Results From a National Survey |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/24698853 https://www.proquest.com/docview/2306320859 https://www.proquest.com/docview/1609504903 https://pubmed.ncbi.nlm.nih.gov/PMC4263934 |
| Volume | 27 |
| WOSCitedRecordID | wos000344601100005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1941-7225 dateEnd: 20151231 omitProxy: false ssIdentifier: ssj0004661 issn: 0895-7061 databaseCode: 7X7 dateStart: 20000101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1941-7225 dateEnd: 20151231 omitProxy: false ssIdentifier: ssj0004661 issn: 0895-7061 databaseCode: BENPR dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Rb9MwELZgQ2gSGjAYdIzKCF6QarWOndnmBY1p1R6gmsZAfYscx1GLSlKSZoh_jy92SovQXnjJi0-OpTv7zr6770PojeQ0tZEVhBuTE55aSqTMJeH5CY9Td2v2HXJfP4rJRE6n6jI8uNWhrLI7E9uDOisNvJEPIVRmQCip3i9_EGCNguxqoNC4i3aBNhuw88VUbPRFtnipI6liIpzj6uBJFRvqb7PhbNmMYrblkLaa3DZizb9LJjd80Pjh_67-EdoP0Sc-9ebyGN2xxQG6_ynk1w_QA_-Kh31z0hOUA8KTbvuSBvj0JzSOuZNxgK-78vQB1kWGz3y9Oy5zfOHutVVbFV8WeF7glp_7Hb6ydbNY1Xhcld-xxgGNe4E_N9WN_fUUfRmfX59dkMDMQEw8ilbEZJyxmGoeK63NCbUyz2iURdS46M86v5hKBUB4wkaGGQWBVabykTBcmBj85iHaKcrCPkc4oyxPnW6MC_W5cbdNyqlNhc4ktTxKWQ-97dSTmABbDuwZi8Snz1niVJl4VfbQ67Xs0oN1_FOq77R8q8Bxp8Qk7Og6-aPBHnq1HnZ7ERIsurBlUycU0PsgleqmeObtZf2bCKg6JUwutixpLQA439sjxXzW4n0Dpr5i_Oj2Zb1Aey6Y475P8hjtrKrGvkT3zM1qXlf9dmO0X9lHux_OJ5dXvwG0FRod |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3fb9MwED6NgQAJ8WMMKIxhBDwgNWodO7ODhNA0qDqtqxB0qG9Z4jhqUUlK0mzaP8XfiC9OSovQ3vbAs0_Or8_nu_i-7wBeS04j7WrhcKUSh0eaOlIm0uHJHvcikzVbhty3gRgO5Xjsf96AXw0XBssqG59YOeo4U_iPvIOhMsOGkv6H-U8Hu0bh6WrTQsPC4khfnJuUrXh_-NF83zeu2_s0Oug7dVcBR3ldd-GomDPm0ZB7fhiqPaplElM3dqkykYs2Pj2SPoq4Ce0qpnwMCmI_6QrFhfLQ55t5r8F148cFlpCJsVjhYVb6rF3pe44wG2Ujh-qzTvh90pnMy67H1jbANVLdSmz7d4nmyp7Xu_e_va37cLeOrsm-XQ4PYEOnW3DzuK4f2II79i8lseSrh5CgglVY8a7aZP8ciXHG87fJqCm_b5MwjcmBrecnWUL6Jm_Pq6r_LCXTlFT9x9-RL7ooZ4uC9PLsBwlJrTY-I1_L_ExfbMPJlTz1I9hMs1Q_ARJTlkQGC8qkMlyZbJpyqiMRxpJq7kasBW8bOASqlmXH7iCzwJYHsMBAJ7DQacGrpe3cipH802rXoOpSg50GNEHtsYrgD2Ja8HI5bHwNHiCFqc7KIqCoTohHxWaKxxafy8u42IpU4uRiDblLA9QxXx9Jp5NKzxx7BviMP738tl7Arf7oeBAMDodHz-C2CVy55YTuwOYiL_VzuKHOFtMi360WJYHTq8b1b5wAcco |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence%2C+awareness%2C+treatment%2C+and+control+of+hypertension+in+China%3A+results+from+a+national+survey&rft.jtitle=American+journal+of+hypertension&rft.au=Wang%2C+Jinwei&rft.au=Zhang%2C+Luxia&rft.au=Wang%2C+Fang&rft.au=Liu%2C+Lisheng&rft.date=2014-11-01&rft.issn=1941-7225&rft.eissn=1941-7225&rft.volume=27&rft.issue=11&rft.spage=1355&rft_id=info:doi/10.1093%2Fajh%2Fhpu053&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0895-7061&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0895-7061&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0895-7061&client=summon |